Wall Street Analysts Believe KalVista Pharmaceuticals (KALV) Could Rally 116.4%: Here's is How to Trade

Core Viewpoint - KalVista Pharmaceuticals, Inc. (KALV) has seen a 1% increase in share price over the past four weeks, closing at $15.61, with analysts suggesting a potential upside of 116.4% based on a mean price target of $33.78 [1] Price Targets - The average price target from nine analysts ranges from a low of $22.00 to a high of $39.00, indicating a standard deviation of $5.4, which reflects the variability of estimates [2] - The lowest estimate suggests a 40.9% increase from the current price, while the highest estimate indicates a 149.8% upside [2] Analyst Sentiment - Analysts show strong agreement regarding KALV's potential for better earnings, as indicated by positive revisions in earnings estimates, which historically correlate with stock price movements [4][11] - The Zacks Consensus Estimate for the current year has risen by 12.6% over the past month, with two estimates increasing and no negative revisions [12] Zacks Rank - KALV holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13] Conclusion on Price Movement - While the consensus price target may not be entirely reliable, the direction indicated by these targets appears to be a useful guide for potential price movement [14]